|
Originally published In Press as doi:10.1074/jbc.M101712200 on June 18, 2001
J. Biol. Chem., Vol. 276, Issue 33, 30862-30870, August 17, 2001
Recognition of E-cadherin by Integrin
E 7
REQUIREMENT FOR CADHERIN DIMERIZATION AND IMPLICATIONS FOR
CADHERIN AND INTEGRIN FUNCTION*
Elaine
Corps ,
Christine
Carter ,
Paula
Karecla ,
Thomas
Ahrens§,
Paul
Evans , and
Peter
Kilshaw ¶
From the Molecular Immunology Programme, The Babraham
Institute, Babraham, Cambridge, CB2 4AT, United Kingdom and the
§ Department of Biophysical Chemistry, Biozentrum,
University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland
Received for publication, February 23, 2001, and in revised form, May 21, 2001
 |
ABSTRACT |
We have investigated the importance of
dimerization of E-cadherin in the heterophilic adhesive interaction
between E-cadherin and integrin E 7.
Dimerization of cadherin molecules in parallel alignment is known to be
essential for homophilic adhesion and has been attributed to
Ca2+-dependent interactions in the domain 1-2 junction or to cross-intercalation of Trp2 from one molecule to the
other. We have disrupted either or both of these proposed mechanisms by
point mutations in E-cadherin-Fc and have tested the modified proteins
for E 7-mediated cell adhesion. Prevention
of Trp2 intercalation had no adverse effect on integrin-mediated adhesion, whereas disruption of Ca2+ binding permitted
adhesion but with reduced efficiency. Both modifications in combination
abolished recognition by E 7. In EGTA,
E 7 adhered to wild type E-cadherin but
not to the Trp2 deletion mutant. Independent evidence that the
mutations prevented either or both mechanisms for dimerization is
presented. The data show that dimerization is required for recognition
by E 7 and that it can take place by
either of two mechanisms. Implications for the roles of the
E and 7 integrin subunits in ligand
binding and for Trp2 and Ca2+ in the assembly of cadherin
complexes are discussed.
 |
INTRODUCTION |
E-cadherin is a homophilic cell adhesion molecule expressed by
epithelial cells. It is a type 1 transmembrane protein that contains
five Ig-like extracellular domains maintained in a rodlike conformation
by interdomain calcium atoms. In addition to its adhesive activity,
E-cadherin has an important role as a cell signaling molecule and
through both activities serves to maintain the integrity of epithelia
(1). E-cadherin is also a counterreceptor for one member of the
integrin family, the mucosal T cell integrin E 7 (2, 3). This heterophilic adhesive
interaction is thought to play a part in the retention of lymphocytes
in or near mucosal epithelia (4). Recently, much attention has been
focused on the molecular mechanisms for the two types of adhesion. A
model has been proposed for homophilic adhesion in which adjacent
cadherin molecules on the cell surface dimerize in parallel alignment
(cis-dimer) and interdigitate with dimers on an opposing cell to form a
zipper-like assembly of multiple low affinity contacts (5). Homophilic adhesion, heterophilic adhesion and cadherin dimerization depend mainly
on contact sites on the extracellular, N-terminal domain EC1.
The mechanism for cadherin dimerization is not yet fully understood.
X-ray crystallographic studies on cadherin domain 1 or domains 1 and 2 together have suggested two alternative mechanisms. Shapiro et
al. (5) observed that domain 1 of N-cadherin formed cis-dimers by
cross-intercalation of Trp2 into a hydrophobic pocket in its
neighboring domain. In contrast, Nagar et al. (6) found that
E-cadherin domains 1 and 2 dimerize through
calcium-dependent hydrogen bonding in the interdomain
junction. Pertz et al. (7) obtained similar results and
showed that Trp2 docked into the hydrophobic pocket of its own domain
rather than providing a bridge to its neighbor. The crystal structure
of N-cadherin domains 1 plus 2 failed to reveal a cis-interaction by
either mechanism (8). Support for Ca2+ dependence of
dimerization has come from observation of purified recombinant cadherin
molecules by electron microscopy (7), atomic force microscopy (9), and
physical measurements of cadherin domains in solution (10).
Investigations into the mechanism of cadherin dimerization on the cell
surface have given a different picture. Cadherin complexes have been
isolated from cell lysates and analyzed by sedimentation or
electrophoresis. In this situation, Trp2 was shown to be essential for
cis-dimer formation (11-14), and Ca2+ was required for the
formation (15) but not the stability (12, 13, 16) of the dimers. It is
not known whether the two proposed mechanisms for dimerization could
operate simultaneously, but the crystal structures of ECAD1,2 (6, 7)
militate against this possibility. Although the precise roles of Trp2
and interdomain calcium are not fully understood, it is widely accepted
that both are required for homophilic adhesion and that
cis-dimerization is an essential part of the process.
Integrin E 7 has been shown to bind to the
distal surface of domain 1 and the contact site has been mapped in
detail. Karecla et al. (17) showed that Glu31 in
the solvent-exposed CD loop was critical for recognition by the
integrin. Recently, this observation has been confirmed and extended to
identify a role also for the FG loop located nearby (18). Higgins
et al. (19) demonstrated that these loops provide a contact
surface for the A-domain of the E integrin subunit. Thus, the acidic side chain of Glu31 docks into the MIDAS
site of the E A domain and Phe298 from the
A-domain is accommodated in a hydrophobic cleft between the BC and FG
loops of E-cadherin. The MIDAS site on the integrin 7
subunit is also required for ligand binding (19, 20) and would be
expected to engage an acidic side chain from the ligand or from the
E subunit, but this has not been identified.
The present report examines the importance of cis-dimerization in the
N-terminal domain of E-cadherin for heterophilic adhesion to
E 7. The two proposed mechanisms for dimer
formation have been investigated. We have prepared a series of
E-cadherin-Fc fusion proteins in which amino acid substitutions have
been made either in the N terminus, to prevent Trp2
cross-intercalation, or in the junction between domains 1 and 2, to
prevent co-ordination of one or more of the three calcium atoms
present. The two categories of modification are referred to as
"single" mutations or, when combined, as "double" mutations.
The recombinant proteins have been tested for their ability to support
E 7-mediated cell adhesion and to
dimerize. None of the amino acid substitutions would be expected to
have any direct effect on the contact site on E-cadherin, which engages
the integrin. The results show that cadherin dimerization is essential
for adhesion to the integrin and provide a new perspective on the
relative importance of Trp2 and the EC1-EC2 interdomain junction for
the formation of cis-dimers.
 |
EXPERIMENTAL PROCEDURES |
Cell Lines and Antibodies
The mouse T cell hybridoma MTC-1 was grown in RPMI 1640 supplemented with 10% FCS1
and 5 ng/ml recombinant transforming growth factor- 2. Under these conditions, the cells expressed high levels of
E 7. The mouse gut epithelial cell line
CMT93, which expresses E-cadherin on the cell surface, was grown in
Dulbecco's modified Eagle's medium plus 10% FCS. The rat monoclonal
antibodies ECCD-2 (21) and DECMA-1 (22), specific for E-cadherin, and
M290 (23), specific for mouse E A-domain, were purified
from culture supernatants. Sheep antisera to two peptides in E-cadherin
domain 1 were prepared. The sequence spanning the BC loop (amino
acids 25-35), KSNRDKETKVF, and that representing the distal part of
the B strand (amino acids 19-30), KNLVQIKSNRDK, were conjugated to
KLH. Sheep were immunized with the conjugates in complete Freund's
adjuvant and boosted twice using incomplete adjuvant.
E-cadherin-Fc Constructs
The extracellular region of mouse E-cadherin, excluding the
signal sequence and propeptide was fused to human IgG1 Fc using the
vector Signal pIg-Tail (R & D Systems), which incorporates a CD33
signal sequence. The construct introduced three additional amino acids
(Met, Asp, and Leu) to the N terminus of fully processed, mature
E-cadherin. The extracellular region extending up to, but not
including, the transmembrane domain was fused to the complete IgG1 Fc
hinge. cDNA for the extracellular region of E-cadherin was prepared
by polymerase chain reaction using Pfu polymerase, introducing BglII restriction sites into the 5' and 3'
primers. In addition, a splice donor site was included in the 3' primer to remove an IgG1 intron so that correct splicing to the IgG1 hinge
exon would take place. Forward primer was
5'-GATCAGATCTAGACTGGGTCATCCCTCCCATCAGC-3'; reverse primer was
5'-GATCAGATCTACTTACCTGTAACTTGCAATCCTGCTGCCACGATT-3'.
Constructs for wild type E-cadherin and all mutants were prepared using
the QuikChange site-directed mutagenesis kit (Stratagene). Mutations
were prepared in the N-terminal region, the Ca2+-binding
region of EC1-2, or in both positions (Table I). Forward primers for
the constructs are listed as follows and were used in conjunction with
their reverse complements: wild type E-cadherin (removal of MDL from
the N terminus),
5'-GCTGTGGGCAGGGGCCCTGGCTGACTGGGTCATCCCTCCCATCAGC-3'; mutation
W2G/V3A (WV),
5'-GCTGTGGGCAGGGGCCCTGGCTGACGGGGCCATCCCTCCCATCAGC-3'; mutation D67A
(Ca1), 5'-GGCTGAAAGTGACACAGCCTCTGGCTAGAGAAGCCATTGCC-3'; mutation
Q101A/N102A (Ca2,3), 5'-GTGATCACAGTGACAGATGCGGCTGACAACAGGCCAGAG-3'; mutation D134A (Ca3), 5'-GGTCTCAGCCACCGCTGCAGACGATGACGTCAAC-3'.
In a second set of mutants, a factor Xa cleavage site (IEGR) was
introduced immediately distal to the Ig hinge region:
5'-GCATGAAGGCGGGAATCGAGGGAAGAGGATTGCAAGTTACAG-3'.
All constructs were sequenced to confirm fidelity. DNA for transfection
into COS cells was prepared using a Plasmid Maxi Kit (Qiagen).
Preparation of E-cadherin-Fc Fusion Proteins
COS7 cells were transfected using a modification of the
DEAE-dextran method (24). After overnight recovery in Dulbecco's modified Eagle's medium plus 10% FCS, the cells were cultured in
Dulbecco's modified Eagle's medium plus 1% FCS for 4-6 days. The
medium was then harvested, cleared of cell debris by centrifugation at
1500 × g, and then centrifuged at 50,000 × g for 1 h. Sterile supernatants were stored at 4 °C.
A representative set of E-cadherin-Fc fusion proteins (WT, MDL, WV,
Ca2,3, WV + Ca2,3, and MDL + Ca2,3) were analyzed by gel filtration
fast protein liquid chromatography on a Superdex-200HR 10/30 column
equilibrated in 50 mM Hepes, pH 7.5, 150 mM
NaCl, 0.05% Tween 20 to verify that they were monodisperse. The double
mutant, Ca2,3 + WV, was susceptible to aggregation on long term
storage, so particular care was taken to ensure that all experiments
were conducted with monodispersed material. The double mutant was also
subjected to N-terminal sequencing to ensure that no degradation had
taken place. E-cadherin-Fc proteins were purified from culture
supernatant by elution from protein A-Sepharose using 0.1 M
glycine/HCl or 50 mM citrate, pH 3.0, followed by immediate
neutralization in Tris and restoration of Ca2+ to 2 mM. Purity was verified by SDS-polyacrylamide gel
electrophoresis. Concentrations were determined by adsorbance at 280 nm.
Enzyme-linked Immunosorbent Assay
The concentration of E-cadherin-Fc in culture supernatants was
determined by enzyme-linked immunosorbent assay using purified E-cadherin-Fc as a standard. 96-well plates were coated overnight with
affinity-purified goat anti-human Fc at 5 µg/ml in PBS. Dilutions of
supernatants containing known quantities of E-cadherin-Fc were incubated on the plate for 1 h at room temperature, and their binding was detected by a similar incubation with biotinylated goat
anti-human Fc (Jackson ImmunoResearch Laboratories), followed by
avidin-horseradish peroxidase (Sigma). Binding of rat monoclonal antibodies DECMA-1 and ECCD-2 (both at 1 µg/ml) to E-cadherin-Fc was
detected using horseradish peroxidase-labeled goat anti-rat IgG
(Chemicon). For titration of sheep antibodies to the BC loop and the
B strand, E-cadherin-Fc proteins were immobilized using rabbit
anti-human Fc (Pierce), and binding of the antibodies was detected with
a mouse monoclonal antibody to sheep IgG (Sigma). With both antisera,
reactivity was specifically inhibited by their respective peptides.
Analytical Ultracentrifugation
Sedimentation equilibrium and sedimentation velocity experiments
were performed at 20 °C using a Beckman Optima XL-A analytical ultracentrifuge (Beckman Instruments) equipped with 12-mm Epon double
sector cells in an An-60 Ti rotor. The proteins were dissolved in 20 mM Tris/HCl, pH 7.9, 100 mM NaCl, and 2 mM CaCl2. The protein concentration was
adjusted to 0.5 mg/ml for sedimentation equilibrium runs and to 0.15 mg/ml for the sedimentation velocity scans. Sedimentation coefficients
were determined by sedimentation velocity experiments at rotor speeds
of 52,000 rpm. The absorbance of the sedimenting material was
measured at 232 nm. Sedimentation coefficients were corrected to
standard conditions (water, 20 °C). Sedimentation equilibrium runs
were carried out at 8000-17,000 rpm, depending on molecular mass.
Apparent molecular masses were evaluated from lnA
versus r2 plots, where A
is the absorbance and r is the distance from the rotor center.
Cell Adhesion Assays
Integrin-mediated Adhesion--
E-cadherin-Fc fusion proteins
were coated to a 96-well enzyme-linked immunosorbent assay plate
(Costar; 3590) via goat anti-Fc as described for enzyme-linked
immunosorbent assays. MTC-1 cells were labeled with BCECF-AM (Molecular
Probes catalog no. B-3051) by incubation in 1 ml of serum-free RPMI
containing 5 µg/ml BCECF-AM for 30-40 min at 37 °C. The cells
were then washed and resuspended at 5 × 105/ml in
assay medium, HBSS (Sigma) containing 1.25 mM
Ca2+ and 0.8 mM Mg2+ plus 1% FCS.
The cells were then activated by the addition of phorbol 12-myristate
13-acetate (15 ng/ml). 5 × 104 cells were added to
each well in a total volume of 200 µl. The plate was centrifuged for
2 min at 16 × g to gently sediment the cells and
then incubated at 37 °C for 30 min. Nonadherent cells were then
removed by gentle pipetting, and the attached cells were quantitated
using a fluorescence plate reader. For assays conducted in the absence
of Ca2+, MTC-1 cells were suspended in Hanks' balanced
saline solution plus 0.1% bovine serum albumin, activated with phorbol
12-myristate 13-acetate, and then washed free of Ca2+ and
transferred to Hanks' balanced saline solution lacking
Ca2+ and Mg2+, supplemented with 0.1% bovine
serum albumin, 1 mM EGTA, and 10 mM
Mg2+. For experiments involving antibody-mediated
inhibition of adhesion, purified IgG antibodies (DECMA-1, ECCD2, M290)
were present in the adhesion assay at 10 µg/ml (DECMA-1 and ECCD2) or
2.5 µg/ml (M290). Adhesion results are expressed as mean percentage
of cells adhering in three or four replicate wells ± S.E.
Homophilic Adhesion--
E-cadherin-Fc fusion proteins were
attached to assay plates as described above. CMT93 cells were
dissociated by chelation (nonenzymatic cell dissociation solution;
Sigma) and maintained in suspension in Dulbecco's modified Eagle's
medium plus 10% FCS at 37 °C for 20 min. They were then transferred
to Hanks' balanced saline solution plus 1% FCS, and 8 × 104 cells were added to each well. The plates were then
incubated at 37 °C for 30 min. Nonadherent cells were washed away,
and residual adherent cells were quantitated by measuring acid
phosphatase activity (25).
Cleavage with Factor Xa
1-2 µg of E-cadherin-Fc bound to 10 µl of protein
A-Sepharose was suspended in 50 µl of 100 mM NaCl, 2 mM CaCl2, 20 mM Tris/HCl, pH 8.0. 1 µg of factor Xa (1 µl at 1 mg/ml; New England Biolabs) was added
and incubated at room temperature for 5 h. Released cadherin
fragments were separated by SDS-polyacrylamide gel electrophoresis and
analyzed by Western blotting using DECMA-1. Residual IgFc on the beads
was released with SDS sample buffer and analyzed by Western blotting
using anti-Fc.
 |
RESULTS |
Production and Characterization of Wild Type and Mutant
E-cadherin-Fc Proteins--
Table I
lists the two categories of E-cadherin mutations: calcium loss mutants
and N-terminal modifications that affect Trp2 intercalation. A third
group of E-cadherin-Fc molecules was prepared in which the two types of
mutation were combined (double mutants). Analytical ultracentrifugation
experiments were performed to determine molecular masses and
sedimentation coefficients of wild type E-cadherin-Fc and the double
mutant, WV + Ca2,3. These proteins represent the two most extreme
situations with respect to possible conformational differences. The
sedimentation coefficients of the wild type and mutant were closely
similar (Table II), which implies that
their frictional coefficients were also similar. Because the shapes proposed for these molecules are complex, these data do not distinguish between the presence or absence of cis-dimerization of cadherin chains
within the Fc fusion proteins. Sedimentation equilibrium experiments
for molecular mass determinations were performed at 17,000 rpm and 8000 rpm. At 17,000 rpm, both wild type and mutant proteins were
monodisperse (Table II). In contrast, sedimentation of the wild type
protein at a lower speed, 8000 rpm, showed the presence of a
predominant species with an apparent molecular mass of 441 kDa, which
is likely to represent E-cadherin-Fc molecules joined in pairs by a low
affinity adhesive trans-interaction. Conversely, the double mutant,
which would not be expected to be active in homophilic adhesion, gave a
heterogeneous mixture of species at 202 and 400 kDa. Although it is not
possible to quantify precisely the two subpopulations, we conclude that
the ability of the mutant protein to form trans-interactions was
greatly impaired. We emphasize that the concentration of E-cadherin-Fc proteins used in adhesion assays was ~100-fold lower than that used
for ultracentrifugation, and under these circumstances all of the
preparations were monodisperse.
View this table:
[in this window]
[in a new window]
|
Table II
Sedimentation Coefficients and Molecular Masses of E-cadherin-Fc WT and
the double mutant E-cadherin-Fc WV + Ca2,3 determined by
analytical ultracentrifugation
|
|
E 7-dependent Adhesion of
MTC-1 Cells to Wild Type or Mutant E-cadherin-Fc Fusion
Proteins--
Fig. 1a
illustrates the basic parameters of the integrin-mediated adhesion
assay and shows adhesion of MTC-1 cells to wild type E-cadherin-Fc
adsorbed to an assay plate via anti-human Fc. Adhesion was completely
inhibited by the anti-mouse E-cadherin antibody ECCD2 and by the
E-specific antibody M290, which recognizes the
E A-domain.2
The antibody DECMA-1, specific for E-cadherin domain 4, had no effect
on integrin-mediated adhesion. Mutant proteins were then compared with
wild type for their ability to support
E 7-mediated adhesion (Fig.
1b). The MDL and WV mutants had no effect on adhesion; nor
did these two modifications in combination. The mutations Ca1, Ca2,3,
and Ca3 supported adhesion but with reduced efficiency. In contrast,
double mutants, in which modifications to the N terminus were combined
with the Ca2+ loss mutations, failed to support adhesion.
Fig. 1c shows that all types of mutation completely
abrogated homophilic adhesion of CMT93 cells to the E-cadherin-Fc
proteins. To gain a more complete picture of the effects of the
mutations on E 7-mediated adhesion, some
of the mutant proteins were titrated in the
integrin-dependent adhesion assay (Fig.
2). The titration curve given by the WV
mutant was identical to that of wild type E-cadherin-Fc (Fig.
2a). In contrast, the mutants Ca2,3 and Ca3 supported
adhesion less efficiently and titrated to background levels of adhesion
at higher coating levels than those observed with wild type E-cadherin
(Fig. 2b). Ca1 behaved similarly (Fig. 2c). These
results are taken from separate experiments, and the differences in
adhesion to wild type E-cadherin reflect interassay variation commonly
experienced in cell adhesion tests of this type, due mainly to
variation in the levels of E 7 expressed
by the MTC-1 cells. Our results with mutants that adversely affect
Ca2+ coordination are broadly consistent with an earlier
report that E 7 can adhere to
E-cadherin-Fc in the absence of Ca2+ (26). We have observed
that Ca2+-independent adhesion of wild type E-cadherin
could be obtained by activating the integrin with 10 mM
Mg2+. Prestimulation of the cells with phorbol 12-myristate
13-acetate before adhesion in the presence of EGTA maximized the
adhesion obtained. Fig. 3 compares
integrin-mediated adhesion with wild type E-cadherin Fc and with the WV
mutant, in the presence of EGTA and 10 mM Mg2+.
Approximately 50% of MTC-1 cells adhered to wild type E-cadherin, but
adhesion to the WV mutant was negligible. This result is consistent with the view that intercalation of Trp2 provides a mechanism for dimer
formation when Ca2+ is lacking. Taken together, the results
from cell adhesion tests suggest that cis-dimerization of E-cadherin by
either mechanism is required for recognition by
E 7 but that dimerization mediated by
Ca2+ in the EC1-EC2 junction gives the preferred
conformation.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
Cell adhesion to E-cadherin-Fc
proteins. Wild type or mutant proteins were coated onto an assay
plate (0.5 µg/ml) and tested for integrin-mediated or homophilic cell
adhesion. a, E 7-mediated
adhesion of MTC-1 cells showing the effect of blocking antibodies
specific for E-cadherin (DECMA-1 and ECCD-2) or E
(M290); b, E 7-mediated
adhesion of MTC-1 cells to wild type E-cadherin-Fc and the panel of
mutants; c, homophilic adhesion of CMT93 epithelial cells to
wild type E-cadherin-Fc and the panel of mutants. The negative control
was provided by wells coated with R-cadherin-Fc. Results are
expressed as mean values ± S.E. from three or four
replicates.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
Ca2+ loss mutants support
E 7-mediated
adhesion less efficiently than WT or N-terminal mutants. Plates
were coated with increasing levels of E-cadherin-Fc proteins.
a, adhesion of MTC-1 cells to WT and WV was closely similar.
In contrast, the Ca2+ loss mutants, Ca2,3 and Ca3
(b) and Ca1 (c), were markedly inferior to WT in
supporting integrin-mediated adhesion. Results show the mean percentage
of cells adhering in three or four replicate wells ± S.E.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
In EGTA, WT E-cadherin-Fc supports
integrin-mediated adhesion, but the Trp2 replacement mutant does
not. MTC-1 cells were activated with phorbol 12-myristate
13-acetate and 10 mM Mg2+ and tested for
adhesion to WT or WV E-cadherin Fc proteins. Cells adhered to the WT
protein but not to the WV mutant.
|
|
Antibodies to Domain 1 Peptides Distinguish Monomers from
Dimers--
Although recognition of E-cadherin dimers by
E 7 provides a plausible explanation for
our results, there remained a less likely alternative possibility that
Ca2+ in the EC1-EC2 junction, or Trp2 in the A strand
could each mediate distant effects on the conformation of the BC loop
that would influence integrin binding. We have addressed this issue through the use of two antisera to peptides in domain 1, one antiserum to a peptide spanning the BC loop and a second to part of the B
strand (Fig. 4). The amino acid sequence
of the latter lies in a cleft at the interface between the two
juxtaposed EC1 domains and, in dimeric E-cadherin, would be
inaccessible to antibodies. The antisera were tested against wild type
or mutant proteins in the presence of varying levels of
Ca2+ or in EGTA. Fig. 5 shows
that the two antisera behaved similarly; reactivity of anti-BC is shown
in Fig. 5a, and reactivity of anti- B is shown in Fig.
5b. The WT and Ca2,3 proteins were not recognized by
peptide-specific antibodies regardless of the presence or absence of
Ca2+. In contrast, the double mutant (WV + Ca2,3), in which
both mechanisms for dimerization were absent, was recognized by both
antibodies under all conditions. The behavior of the WV mutant in these
assays depended on the level of Ca2+. No binding was
detected in the presence of 1.25 mM or 0.5 mM Ca2+, but, when the concentration was reduced to 0.125 mM, weak reactivity was just detectable, and in
Ca2+-free Tris or EGTA, antibody binding was maximal. The
similar behavior of the two antibodies can be explained by the
inability of either of them to recognize dimeric E-cadherin. The B
epitope was selected specifically to be inaccessible in the dimer, but the epitope on the BC loop is exposed. Molecular modeling with cadherin
dimers and Fab fragments (not shown) strongly suggests that access by
an IgG molecule to the BC loop would be compromised in the dimer by the
close proximity of the two EC1 domains.

View larger version (82K):
[in this window]
[in a new window]
|
Fig. 4.
Location of peptides in E-cadherin domain 1 used to produce antisera. a, the amino acid sequence,
KSNRDKETKVF, which spans the BC loop (the underlined E is
Glu31); b, the sequence KNLVQIKSNRDK, which
covers the B strand. The structure of the EC1,2 dimer is taken from
Pertz et al. (7).
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 5.
Reactivity of E-cadherin-Fc proteins with two
peptide antisera in varying concentrations of calcium.
a, antiserum to the BC loop; b, antiserum to the
B strand. Antibody binding tests were performed in EGTA
( ), Ca2+-free TBS ( ), 0.125 mM
Ca2+ ( ), 0.5 mM Ca2+ ( ), or
1.25 mM Ca2+ ( ). Both antisera recognized
the cadherin monomer only.
|
|
Conformational Changes in E-cadherin-Fc Proteins--
A Factor Xa
cleavage site was introduced into wild type and five mutant E-cadherin
Fc proteins, immediately distal to the three disulfide bonds of the Ig
hinge, to allow release of the extracellular domains of E-cadherin. The
presence of this site had no effect on the functional activity of the
proteins in heterophilic or homophilic adhesion tests nor on reactivity
with our peptide-specific antibodies. All of the preparations were
shown to be monodisperse by fast protein liquid chromatography. We
observed striking, consistent differences in the digestion products of
the mutant Fc fusion proteins following treatment with factor Xa. The
pattern correlated with the ability of the mutants to support
E 7-mediated adhesion and to form dimers.
Fig. 6a shows a Western blot
of the digestion products seen with our panel of mutants. Introduction
of the cleavage site into WT E-cadherin caused factor Xa to release an
86-kDa fragment corresponding to the EC1-5. A similar pattern was seen with the MDL and WV mutants. In contrast, the Ca2,3 mutant gave a
closely spaced double band at ~170 kDa in addition to the expected product at 86 kDa. The double mutants, WV + Ca2,3 and MDL + Ca2,3, gave
a single band at 170 kDa and the expected 86-kDa product. Upon
reduction, all digestion products were resolved at 86 kDa (Fig.
6b). These results demonstrate that factor Xa cleaved some of the mutants at nonspecific sites near the Ig hinge, in close proximity to the expected position, to give a 170-kDa disulfide-bonded product. Analysis of the residual material remaining on the Sepharose beads after digestion (i.e. the remaining IgFc) gave a
50-kDa band before reduction (Fig. 6c) and a 25-kDa band
after reduction (Fig. 6d), demonstrating that the aberrant
cleavage sites were within the Ig hinge and were flanked on either side
by disulfide bonds. The patterns of cleavage shown in Fig. 6 were seen
in all experiments performed and with separate preparations of the
E-cadherin-Fc proteins. We attribute the altered pattern of cleavage to
major conformation changes in the proteins, specifically to the
introduction of greater segmental flexibility and dynamic freedom in
the hinge region caused by failure of cis-dimer formation by the double mutants. In the case of the Ca2,3 mutant, which we argue is dimerized by Trp2 cross-intercalation, the loss of Ca2+ at the
EC1-EC2 junction would introduce freedom of movement between EC1 and
EC2 (27), and, because the other domain junctions in the cadherin
molecule are relatively rigid, this increased freedom would be
transmitted to the Ig hinge. In this case, two closely spaced aberrant
factor Xa cleavage sites were present. In effect, loss of interdomain
Ca2+ or failure of dimerization at the level of domain 1 causes the molecule to flex more at the hinge. Cleavage by factor Xa is
acting as a sensitive indicator of conformational change. Nonspecific cleavage by factor Xa is known to occur in regions of high flexibility and at lysyl residues (28, 29); both criteria are fulfilled in the
circumstances of our experiments. Cumulative evidence from the present
results and from previous studies on the role of Ca2+ and
Trp2 in dimer formation suggests that our E-cadherin-Fc proteins adopt
the conformations proposed in Fig. 7.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
Cleavage of E-cadherin-Fc proteins with
factor Xa reflects conformational changes in the IgFc hinge. A
factor Xa cleavage site (FXa) was introduced into the
N-terminal side of the IgFc hinge in our panel of proteins. The
products released after digestion with factor Xa were separated by
SDS-polyacrylamide gel electrophoresis under nonreducing (a) or
reducing (b) conditions and were detected by Western
blotting with DECMA-1. WT E-cadherin-Fc lacking a factor Xa site was
not cleaved by factor Xa (left-hand track). In the other
proteins, the band at ~86 kDa represents E-cadherin EC1-EC5. The
products at ~170 kDa are paired EC1-EC5 units joined together by
disulfide bonds within the IgFc hinge. The paired EC1-EC5 units became
separated upon reduction (b). The result shows that aberrant
cleavage occurred in E-cadherin-Fc proteins in which dimerization via
EC1 had failed or was maintained by Trp2 only. Residual IgFc remaining
after release of EC1-EC5 was separated under nonreducing (c)
or reducing (d) conditions and detected by blotting with
anti-Fc; products were present at 50 and 25 kDa, respectively,
representing disulfide-bonded or single Fc chains. This result confirms
that aberrant cleavage occurred at sites within the Ig hinge, flanked
on either side by disulfide bonds. The high MW bands in c
and d represent small amounts of residual intact or
partially digested E-cadherin-Fc remaining on the beads.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 7.
Proposed structures of the wild type
and mutant E-cadherin-Fc proteins. The model on the
left shows the Ca2+-dependent dimer,
which has a relatively firm structure with little flexibility at the
EC1-EC2 junction. The center model shows the
Trp2-dependent dimer, which has lost rigidity at the
EC1-EC2 junction when Ca2+ is lacking here and therefore is
permitted flexibility in the directions of the arrows. The
third model has lost the capacity to dimerize and
shows free flexibility at the Ig hinge. All models would be expected to
show some flexibility also at right angles to the plane of the paper.
Positions of the factor Xa cleavage site and the three disulfide bonds
are shown.
|
|
 |
DISCUSSION |
The primary aim of this study was to determine whether
cis-dimerization of E-cadherin is required for recognition by
E 7. We chose E-cadherin-Fc proteins for
the analysis because the disulfide bonds of the Ig hinge would hold the
membrane-proximal regions of paired cadherin molecules in close
apposition. This may simulate the situation on the cell membrane when
regulatory mechanisms acting on the cytoplasmic domain favor cadherin
clustering (30, 31). Huber et al. (32) have demonstrated
that transmembrane segments of E-cadherin cluster together, possibly by
a leucine zipper-type mechanism, and have proposed that this mechanism
acts in concert with cis-interactions at domain 1 to stabilize the dimer. At low Ca2+ concentrations, other ectodomains may
also be involved (33). We have focused specifically on cis-interactions
at domain 1. The mutations in the N-terminal region of domain 1 and in
the Ca2+ binding sites in the EC1-EC2 junction were
selected to investigate the two proposed mechanisms for dimerization.
We extended the N terminus by three amino acids, MDL, because this
would be expected to interfere with the cross-intercalation of Trp2
between domain pairs (5) or docking into its own domain (7). As
predicted, results with this mutant were identical to those with the WV
mutant and are consistent with previous reports that correct cleavage of the N terminus (34) and the presence of Trp2 (12, 13,) are both
essential for cadherin function. Mutations of amino acids coordinating
Ca1, Ca2,3, or Ca3 were selected by reference to two published crystal
structures (6, 7) and a previous report (35) that the Ca3 mutant
(Asp134 Ala) prevents homophilic adhesion. The Ca2,3
mutant (Q101A/N102A) removed Gln101, which is thought to
play a key role in hydrogen bonding between the domain pair (6). The
binding site for Ca1 was targeted because it is thought to have a lower
affinity for Ca2+ than the other two sites (7, 27) and to
be required for homophilic adhesion but not dimer formation (7). Our
results with Ca1 were, however, similar to those with the other two
calcium loss mutants. Calcium binding has not yet been measured
empirically in these mutants, so it is not absolutely certain that we
achieved selectivity for particular calcium atoms; loss of a single
calcium ligand may have destabilized the junctional region as a whole.
Prevention of Trp2 intercalation alone was shown to have no effect on
integrin-mediated adhesion, and loss of one or more calcium atoms in
the EC1-EC2 junction permitted
E 7-mediated adhesion but with reduced
efficiency. The two types of modification in combination completely
prevented adhesion, which implies that integrity of one or the other
mechanism for dimerization was required. A reciprocal relationship
between Trp2 and interdomain Ca2+ was confirmed by the
observation that integrin-mediated adhesion in the presence of EGTA was
abrogated by the removal of Trp2.
Binding of peptide antibodies specific for the BC loop or the B
strand strongly supports our contention that dimers can form by either
mechanism. The antibodies bound to double mutants, which should not
form dimers, but did not bind to wild type or single mutants in which
dimerization would be expected. Experiments with the Trp2 replacement
mutant, WV, demonstrated that the
Ca2+-dependent mechanism required
Ca2+ concentrations higher than 125 µM. At
this level, the first indication of dissociation into monomers was detected.
Attempts to monitor dimerization by chemical cross-linking experiments
with E-cadherin-Fc have been unsuccessful for technical reasons.
Similarly, electron microscopic observations on the proteins have been
confounded by disruption of the dimeric conformation during the
preparative procedures. Nevertheless, our studies with factor Xa
proteolysis have provided additional evidence for major conformational
changes consistent with the presence of absence of dimers. Generation
of nonspecific cleavage products in the IgFc hinge using factor Xa can
be adequately explained by differences in flexibility at the Ig hinge
related to dimerization at the level of EC1. To our knowledge, this is
a novel use of a restriction peptidase to monitor conformational
changes in a protein.
Another laboratory recently reported that dimerization of E-cadherin
was unnecessary for either E 7-mediated
adhesion or homophilic adhesion (36). The authors observed that
unmodified E-cadherin-Fc fusion protein that had been reduced and
alkylated in the Ig hinge and was assumed to be monomeric functioned
normally in either type of assay. The interpretation is, however,
flawed, because in these circumstances strong noncovalent interactions between the CH3 domains of the paired Fc regions would have maintained the dimeric structure (37, 38).
Implications for Integrin Function--
In principal, a
dimeric ligand could either bind two separate integrin molecules by
monovalent interactions or one integrin molecule in a bivalent manner.
Recent studies on the crystal structure of the ICAM-1 dimer suggest
that monovalency is likely in the interaction with LFA-1 (39). The
critical Glu34 integrin contact residues in the ICAM-1
dimer are located on outward facing surfaces on opposite sides of the
molecule a maximum distance apart, about 4.2 nm (39). In contrast, the
two Glu31 residues that lie side by side on the top surface
of dimeric E-cadherin and are recognized by
E 7 are more closely spaced, about 2.4 nm
apart. A convincing model has recently been proposed for the
interaction between the A-domain of the E integrin
subunit and the top surface of E-cadherin domain 1, involving docking of E-cadherin Glu31 into the E MIDAS site
(19). It is doubtful whether two E A-domains could dock
simultaneously onto the E-cadherin dimer. Additional steric constraints
imposed by the -propeller of the -subunit and the presence of the
7 subunit in the intact integrin would make this
stoichiometry highly unlikely. An alternative explanation is that
contact residues from each component of the EC1 domain pair are
recognized by a single E 7 molecule. If
so, the spatial relationships between the exposed acidic side chains on
the top surfaces of the two cadherin molecules would be critical for
integrin binding. The Ca2+-dependent dimer
would present the paired recognition sites in a relatively firm
structure. By contrast, the Trp2-dependent dimer would
permit freedom of movement of the two EC1 domains relative to one
another, which would compromise correct spacing of the contact sites.
This could explain why integrin binding was less efficient in the
Ca2+ loss mutants.
It is clear from mutagenesis studies (19) and from epitope
mapping of blocking antibodies (20, 40) that the A-like domain of the
7 subunit, especially the MIDAS cleft within it, is
essential for cadherin recognition. It is possible that the A-like
domain of the 7 subunit may dock to an acidic side chain
on the top surface of one component of the dimer, while the
E A-domain engages Glu31 from the other
component. Direct evidence for this is not yet available. It has been
proposed that, in general, the integrin -subunit A-like domain
functions to regulate ligand-binding by the A-domain of the -subunit
and, in integrins that lack an -subunit A-domain, directly
participates in ligand binding (41). Structural models have been
proposed for both situations (41, 42). Recent experiments in which the
L A-domain has been locked by mutagenesis into an
"open" conformation have shown that the ligand binding activity of
LFA-1 is attributable entirely to the chain A-domain and that the
subunit performs a regulatory role (43, 44). In suggesting ligand
engagement by both and subunits, we envisage that
E may be a special case. Why should this be so? The
E 7 integrin is unusual in two respects.
First, expression is normally confined to intraepithelial lymphocytes
in the gut, a population of highly cytotoxic, potentially
self-reactive, effector T cells specialized for a local tissue-specific
function (45). Second, only one ligand, E-cadherin, has been identified
for E 7. Recently, weak
cadherin-independent binding to an unidentified ligand on intestinal
microvascular endothelial cells has also been reported (46), but the
physiological significance of this is not clear. Tightly restricted
ligand-binding specificity may be necessary for
E 7 because it is important that
potentially autoreactive mucosal T cells be retained in their correct
location. Ligand recognition requiring ligand contact by both integrin
subunits would provide a mechanism for ensuring more precise
specificity than that seen in other integrins. A recent report that
E-deficient mice develop an inflammatory skin disorder
(47) is consistent with the idea that correct tissue
compartmentalization of these effector T cells is important.
Two Mechanisms for Cis-dimerization--
Evidence on the
role of Ca2+ in cis-dimerization is complex and partly
conflicting. The average dissociation constant for calcium binding in
the junction between domains 1 and 2 has been variously estimated to be
23 µM (10) and 460 µM (27), and it is
possible that one calcium atom is bound with much lower affinity, 2 mM (27). The higher values are in a range at which
physiological changes in extracellular calcium, as a consequence, for
example, of the operation of calcium channels in the cell membrane,
could regulate calcium binding at the EC1-EC2 junction and modulate adhesion. Pertz et al. (7) have proposed a model for
homophilic adhesion in which cis-dimerization occurs entirely in a
Ca2+-dependent manner and Trp2 intercalates
into its own domain. The insertion of Trp2 causes a conformational
change on the CFG surface that is required for an adhesive
trans-interaction with E-cadherin on an opposing cell. The model
predicts that reduction in Ca2+ concentration to ~500
µM will release Trp2 from the hydrophobic pocket with
consequent loss of homophilic adhesion. On the basis of our present
data, we propose an alternative model. In this case, cis-dimerization
in an isolated dimeric molecule is maintained primarily by calcium
atoms at the domain 1-2 junction. Structural constraints imposed by
Ca2+ favor intercalation of Trp2 into its own domain. If
Ca2+ levels are reduced, one or more of the interdomain
calcium atoms are lost, and the EC1-EC2 junction becomes more flexible.
Trp2 then cross-intercalates to maintain the dimer. The adhesive
trans-interaction, which occurs in the presence of Ca2+,
may also modify the orientation of the EC1 domains sufficiently to
encourage Trp2 cross-intercalation. Thus, the function of
Ca2+ is to initiate formation of the dimer and to hold the
domain junction rigid for the trans-interaction to take place. The
primary role of Trp2 is to maintain the dimeric structure in the
adhesive complex. Our experiments show that the Trp2 dimer is very
stable and is maintained even when the whole cadherin molecule
collapses as a result of calcium chelation.
The present data have helped to reconcile two seemingly conflicting
views on the mechanism of E-cadherin dimerization by showing that both
are valid and may reflect different phases in the assembly of cadherin complexes.
 |
ACKNOWLEDGEMENT |
We are very grateful to Dr Ariel Lustig
(Biozentrum, University of Basel) for performing analytical
ultracentrifugation experiments.
 |
FOOTNOTES |
*
This work was supported by the Biotechnology and Biological
Sciences Research Council, UK.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: The Babraham
Institute, Babraham, Cambridge CB2 4AT, United Kingdom. Tel.: 44 1223 496553; Fax: 44 1223 496023; E-mail: peter.kilshaw@bbsrc.ac.uk.
Published, JBC Papers in Press, June 18, 2001, DOI 10.1074/jbc.M101712200
2
P. Kilshaw, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
FCS, fetal calf
serum;
WT, wild type.
 |
REFERENCES |
| 1.
|
Vleminckx, K.,
and Kemler, R.
(1999)
Bioessays
21,
211-220
|
| 2.
|
Cepek, K. L.,
Shaw, S. K.,
Parker, C. M.,
Russell, G. J.,
Morrow, J. S.,
Rimm, D. L.,
and Brenner, M. B.
(1994)
Nature
372,
190-193
|
| 3.
|
Karecla, P. I.,
Bowden, S. J.,
Green, S. J.,
and Kilshaw, P. J.
(1995)
Eur. J. Immunol.
25,
852-856
|
| 4.
|
Schon, M. P.,
Arya, A,
Murphy, E. A.,
Adams, C. M.,
Strauch, U. G.,
Agace, W. W.,
Marsal, J.,
Donohue, J. P.,
Her, H.,
Beier, D. R.,
Olson, S.,
Lefrancois, L.,
Brenner, M. B.,
Grusby, M. J.,
and Parker, C. M.
(1999)
J. Immunol.
162,
6641-6649
|
| 5.
|
Shapiro, L.,
Fannon, A. M.,
Kwong, P. D.,
Thompson, A.,
Lehmann, M. S.,
Grubel, G.,
Legrand, J-F,
Als-Nielsen, J.,
Colman, D. R.,
and Hendrickson, W. A.
(1995)
Nature
374,
327-337
|
| 6.
|
Nagar, B.,
Overduin, M.,
Ikura, M.,
and Rini, J. M.
(1996)
Nature
380,
360-364
|
| 7.
|
Pertz, O.,
Bozic, D.,
Koch, A. W.,
Fauser, C.,
Andrea Brancaccio, A.,
and Engel, J.
(1999)
EMBO J.
18,
1738-1747
|
| 8.
|
Tamura, K.,
Shan, W-S.,
Hendrickson, W. A.,
Colman, D. R.,
and Shapiro, L.
(1998)
Neuron
20,
1153-1163
|
| 9.
|
Baumgartner, W.,
Hinterdorfer, P.,
Ness, W.,
Raab, A.,
Vestweber, D.,
Schindler, H.,
and Drenckhahn, D.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
4005-4010
|
| 10.
|
Alattia, J-R.,
Ames, J. B.,
Porumb, T.,
Tong, K. I.,
Heng, Y. M.,
Ottensmeyer, P.,
Kay, C. M.,
and Ikura, M.
(1997)
FEBS Lett.
417,
405-408
|
| 11.
|
Shan, W-S.,
Tanaka, H.,
Phillips, G. R.,
Arndt, K.,
Yoshida, M.,
Colman, D. R.,
and Shapiro, L.
(2000)
J. Cell Biol.
148,
579-590
|
| 12.
|
Chitaev, N. A.,
and Troyanovsky, S. M.
(1998)
J. Cell Biol.
142,
837-846
|
| 13.
|
Kitagawa, M.,
Natori, M.,
Murase, S.,
Hirano, S.,
Taketani, S.,
and Suzuki, S. T.
(2000)
Biochem. Biophys. Res. Commun.
271,
358-363
|
| 14.
|
Klingelhofer, J.,
Troyanovsky, R. B.,
Laur, O. Y.,
and Troyanovsky, S.
(2000)
J. Cell Sci.
113,
2829-2836
|
| 15.
|
Takeda, H.,
Shimoyama, Y.,
Nagafuchi, A.,
and Hirohashi, S.
(2000)
Nat. Struct. Biol.
6,
310-312
|
| 16.
|
Brieher, W. M,
Yap, A. S.,
and Gumbiner, B. M.
(1996)
J. Cell Biol.
135,
487-496
|
| 17.
|
Karecla, P. I.,
Green, S. J.,
Bowden, S. J.,
Coadwell, J.,
and Kilshaw, P. J.
(1996)
J. Biol. Chem.
271,
30909-30915
|
| 18.
|
Taraszka, K. S.,
Higgins, J. M. G.,
Tan, K.,
Mandelbrot, D. A.,
Wang, J. H.,
and Brenner, M. B.
(2000)
J. Exp. Med.
191,
1555-1567
|
| 19.
|
Higgins, J. M. G.,
Cernadas, M.,
Tan, K.,
Irie, A.,
Wang, J. H.,
Takada, Y.,
and Brenner, M. B.
(2000)
J. Biol. Chem.
275,
25652-25664
|
| 20.
|
Tidswell, M.,
Pachynski, R.,
Wu, S. W.,
Qui, S. Q.,
Dunham, E.,
Cochran, N.,
Briskin, M. J.,
Kilshaw, P. J.,
Lazaovits, A. I.,
Andrew, D. P.,
Butcher, E. C.,
Yednock, T. A.,
and Erle, D. J.
(1997)
J. Immunol.
159,
1497-1505
|
| 21.
|
Sirayoshi, Y.,
Nose, A.,
Iwasaki, K.,
and Takeichi, M.
(1986)
Cell Struct. Funct.
11,
245-252
|
| 22.
|
Ozawa, M.,
Hoshutzky, H.,
Herrenknecht, K.,
and Kemler, R.
(1990)
Mech. Dev.
33,
49-56
|
| 23.
|
Kilshaw, P. J.,
and Baker, K. C.
(1988)
Immunol. Lett.
18,
149-154
|
| 24.
|
Gonzalez, A. L.,
and Joly, E.
(1995)
Trends Genet.
11,
216-217
|
| 25.
|
Tolosa, E.,
and Shaw, S.
(1996)
J. Immunol. Methods
192,
165-172
|
| 26.
|
Higgins, J. M. G.,
Mandelbrot, D. A.,
Shaw, S. K.,
Russell, G. J.,
Murphy, E. A.,
Chen, Y. T.,
Nelson, W. J.,
Parker, C. M.,
and Brenner, M. B.
(1998)
J. Cell Biol.
140,
197-210
|
| 27.
|
Koch, A. W.,
Pokutta, S.,
Lustig, A.,
and Engel, J.
(1997)
Biochemistry
36,
7697-7705
|
| 28.
|
Wearne, S. J.
(1990)
FEBS Lett.
263,
23-26
|
| 29.
|
Nakashima, A.,
Mori, K.,
Nagatsu, T.,
and Ota, A.
(1999)
J. Neural Transm.
106,
819-824
|
| 30.
|
Ozawa, M.,
and Kemler, R.
(1998)
J. Cell Biol.
142,
1605-1613
|
| 31.
|
Ozawa, M.,
and Kemler, R.
(1998)
J. Biol. Chem.
273,
6166-6170
|
| 32.
|
Huber, 0.,
Kemler, R.,
and Langosch, D.
(1999)
J. Cell Sci.
112,
4415-4423
|
| 33.
|
Troyanovsky, R. B.,
Klingelhofer, J.,
and Troyanovsky, S.
(1999)
J. Cell Sci.
112,
4379-4387
|
| 34.
|
Ozawa, M.,
and Kemler, R.
(1990)
J. Cell Biol.
111,
1645-1650
|
| 35.
|
Ozawa, M.,
Engel, J.,
and Kemler, R.
(1990)
Cell
63,
1033-1038
|
| 36.
|
Berg, R. W.,
Yang, Y.,
Lehnert, K.,
and Krissansen, G. W.
(1999)
Immunol. Cell Biol.
77,
337-344
|
| 37.
|
Thies, M. J.,
Mayer, J.,
Augustine, J. G.,
Frederick, C. A.,
Lilie, H.,
and Buchner, J.
(1999)
J. Mol. Biol.
293,
67-79
|
| 38.
|
Dall'Acqua, W.,
Simon, A. L.,
Mulkerrin, M. G.,
and Carter, P.
(1998)
Biochemistry
37,
9266-9273
|
| 39.
|
Casasnovas, J. M.,
Stehle, T.,
Liu, J-H.,
Wang, J. H.,
and Springer, T. A.
(1998)
Proc. Natl. Acad. Sci.
95,
4134-4139
|
| 40.
|
Andrew, D. P.,
Berlin, C.,
Honda, S.,
Yoshino, T.,
Hamann, A.,
Holzmann, B.,
Kilshaw, P. J.,
and Butcher, E. C.
(1994)
J. Immunol.
153,
3847-3861
|
| 41.
|
Zang, Q.,
Lu, C.,
Huang, C.,
Takagi, J.,
and Springer, T. A.
(2000)
J. Biol. Chem.
275,
22202-22212
|
| 42.
|
Purzon-McLaughlin, W.,
Kamata, T.,
and Takada, Y.
(2000)
J. Biol. Chem.
275,
7795-7802
|
| 43.
|
Lu, C.,
Shimaoka, M.,
Ferzly, M.,
Oxvig, C.,
Takagi, J.,
and Springer, T. A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
2387-2392
|
| 44.
|
Lu, C.,
Shimaoka, M.,
Zang, Q.,
Takagi, J.,
and Springer, T. A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
2393-2398
|
| 45.
|
Beagley, K. W.,
and Husband, A. J.
(1998)
Crit. Rev. Immunol.
18,
237-254
|
| 46.
|
Strauch, U. G.,
Mueller, R. C.,
Li, X. Y.,
Cernadas, M.,
Higgins, J. M. G.,
Binion, D. G.,
and Parker, C. M.
(2001)
J. Immunol.
166,
3506-3514
|
| 47.
|
Schon, M. P.,
Schon, M.,
Warren, H. B.,
Donohue, J. P.,
and Parker, C. M.
(2000)
J. Immunol.
165,
6583-6589
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. L. Floc'h, A. Jalil, I. Vergnon, B. L. M. Chansac, V. Lazar, G. Bismuth, S. Chouaib, and F. Mami-Chouaib
{alpha}E{beta}7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis
J. Exp. Med.,
March 19, 2007;
204(3):
559 - 570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. Kan, M. P. Stemmler, D. Junghans, B. Kanzler, W. N. de Vries, M. Dominis, and R. Kemler
Gene replacement reveals a specific role for E-cadherin in the formation of a functional trophectoderm
Development,
January 1, 2007;
134(1):
31 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Lovett, I. Gonzalez, D. A. M. Salih, L. J. Cobb, G. Tripathi, R. A. Cosgrove, A. Murrell, P. J. Kilshaw, and J. M. Pell
Convergence of Igf2 expression and adhesion signalling via RhoA and p38 MAPK enhances myogenic differentiation
J. Cell Sci.,
December 1, 2006;
119(23):
4828 - 4840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. J. Harrison, E. M. Corps, and P. J. Kilshaw
Cadherin adhesion depends on a salt bridge at the N-terminus
J. Cell Sci.,
September 15, 2005;
118(18):
4123 - 4130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Shiraishi, K. Tsuzaka, K. Yoshimoto, C. Kumazawa, K. Nozaki, T. Abe, K. Tsubota, and T. Takeuchi
Critical Role of the Fifth Domain of E-Cadherin for Heterophilic Adhesion with {alpha}E{beta}7, But Not for Homophilic Adhesion
J. Immunol.,
July 15, 2005;
175(2):
1014 - 1021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. J. Harrison, E. M. Corps, T. Berge, and P. J. Kilshaw
The mechanism of cell adhesion by classical cadherins: the role of domain 1
J. Cell Sci.,
February 15, 2005;
118(4):
711 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mareel and A. Leroy
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Physiol Rev,
April 1, 2003;
83(2):
337 - 376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ozawa
Lateral Dimerization of the E-cadherin Extracellular Domain Is Necessary but Not Sufficient for Adhesive Activity
J. Biol. Chem.,
May 24, 2002;
277(22):
19600 - 19608.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|